Deadly flesh-eating ‘zombie’ drug given to dogs has infiltrated the UK

[Social Media]

 

The infiltration of the deadly flesh-eating drug xylazine into the UK's drug market has raised significant concerns among researchers and experts. Here are the key points highlighted in the research findings:

 

1. Introduction of Xylazine: Xylazine, primarily used as an animal tranquilizer, has made its way into the UK's illegal drug market. It has been linked to at least 11 deaths in the UK and is known to cause necrotic skin ulcers, leading to severe health complications and potential fatalities.

 

2. Risk Factors: Xylazine poses significant risks to users, including lethal overdose and the development of painful necrotic sores. It is often combined with other substances, such as fentanyl, to enhance its effects and recreate the highs experienced by heroin users.

 

3. Infiltration of Various Drugs: Xylazine has been detected in a wide range of illicit substances in the UK, including cocaine, counterfeit codeine, diazepam (Valium) tablets, and THC cannabis vapes. This indicates its widespread presence and potential for harm across different drug markets.

 

4. Challenges in Detection: Prior to the detection of xylazine-related deaths, there was limited testing for the drug in the UK. Lack of awareness and testing contributed to its unnoticed presence in the drug supply chain.

 

5. Public Health Concerns: The emergence of xylazine in the UK's drug market presents a significant public health threat, requiring urgent action to prevent a crisis similar to the one seen in the US. Chronic skin ulcers caused by xylazine use pose long-term health risks, including the need for limb amputations.

 

6. Call for Action: Researchers and experts have called for improved testing methods, better awareness among healthcare providers, and specific toxicology testing for xylazine in relevant cases to understand its true prevalence and mitigate its harms.

 

7. Government Response: The UK government intends to classify xylazine as a Class-C drug, subjecting anyone supplying the substance to up to 14 years in prison, a fine, or both. This action aims to address the threat posed by xylazine and other illicit synthetic drugs.

 

Overall, the infiltration of xylazine into the UK's drug market underscores the importance of proactive measures to identify and address emerging threats to public health posed by illicit substances.

 

11.04.24

Source

 

[retarius]

Tranq has been since the 60s or 70s. I'm surprised that they are finding the flesh eating 'necrotic' sores just now?